Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
Launched by COPENHAGEN RESPIRATORY RESEARCH · Mar 18, 2025
Trial Information
Current as of April 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥40 years
- • Chronic obstructive pulmonary disease with acute exacerbation, unspecified: ICDJ44
- Exclusion Criteria:
- • All diagnoses that would merit treatment with a specific corticosteroid
- • Pregnant or breastfeeding women
- • Active tuberculosis or invasive fungal infection
Trial Officials
Jens-Ulrik Stæhr Jensen, MD, PHD
Study Director
COP:RESP
About Copenhagen Respiratory Research
Copenhagen Respiratory Research is a leading clinical trial sponsor dedicated to advancing respiratory health through innovative research and development. Based in Copenhagen, the organization focuses on conducting high-quality clinical trials aimed at uncovering new therapies and treatment modalities for respiratory diseases. With a commitment to scientific excellence and patient safety, Copenhagen Respiratory Research collaborates with academic institutions, healthcare providers, and industry partners to drive forward the understanding of respiratory conditions and improve patient outcomes. Their multidisciplinary team of experts leverages cutting-edge technology and methodologies to ensure the success of their clinical programs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
